Your email has been successfully added to our mailing list.

×
0 -0.016304347826087 -0.0135869565217391 -0.0108695652173913 0.108695652173913 0.0978260869565217 0.168478260869565 0.263586956521739
Stock impact report

Accord BioPharma Announces Agreement by Intas Pharmaceuticals, Ltd. to Acquire UDENYCA® (pegfilgrastim-cbqv) Business from Coherus BioSciences, Inc., Unlocking Potential for Continued U.S....

Coherus BioSciences, Inc. (CHRS) 
Last coherus biosciences, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.coherus.com
Company Research Source: Yahoo! Finance
UDENYCA is a biosimilar to Neulasta, used to decrease the incidence of infection in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs. The acquisition is expected to expand Accord BioPharma's product portfolio and position the company for accelerated growth in the biosimilar industry. The deal is expected to close in the first quarter of 2025, and Accord BioPharma will welcome employees from Coherus to help inform and expand work around UDENYCA. Agreement demonstrates the expanding leadership of Accord BioPharma and Intas in the biosimilar market RALEIGH, N.C. Dec. 3, 2024 /PRNewswire/ -- Accord BioPharma , Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd. ("Intas Pharmaceuticals"), focused on the development of oncology, immunology and critical care therapies, announced today that Intas Pharmaceuticals has signed an agreement to acquire the UDENYCA® (pegfilgrastim-cbqv) business from Coherus BioSciences, Inc. ("Coherus"). UDENYCA i Show less Read more
Impact Snapshot
Event Time:
CHRS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
CHRS alerts

from News Quantified
Opt-in for
CHRS alerts

from News Quantified